Joan Shaw
Chief Tech/Sci/R&D Officer at BELLUS HEALTH
Joan Shaw active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BELLUS HEALTH | Chief Tech/Sci/R&D Officer | 29/02/2020 | - |
Career history of Joan Shaw
Former positions of Joan Shaw
| Companies | Position | Start | End |
|---|---|---|---|
| ATHERONOVA INC. | Chief Tech/Sci/R&D Officer | 07/01/2013 | - |
Training of Joan Shaw
| University of Delaware | Undergraduate Degree |
| West Chester University of Pennsylvania | Graduate Degree |
Statistics
International
| United States | 4 |
| Canada | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
AtheroNova, Inc.
 AtheroNova, Inc. Pharmaceuticals: MajorHealth Technology AtheroNova, Inc. operates as biotechnology company. The company engages in the research and development, marketing, and sale of pharmaceutical preparations and pharmaceutical intellectual property. It develops intellectual property that uses certain pharmacological compounds for the treatment of atherosclerosis, which is the primary cause of various cardiovascular diseases. The company was founded by Giorgio Zadini and Filiberto Zadini in 1997 and is headquartered in Irvine, CA. | Health Technology |
BELLUS Health, Inc.
 BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
- Stock Market
- Insiders
- Joan Shaw
- Experience
